1451093-07-4

Upstream product

• 372-39-4 3,5-difluoroaniline 
• 106-53-6 para-bromobenzenethiol 
• 2265-91-0 1,3-difluoro-5-iodobenzene 

Downstream Products

• 1451093-54-1 {4-[4-(3,5-difluoro-phenylsulfanyl)-phenyl]-6-fluoro-3-methyl-naphthalen-2-yl}-acetic acid methyl ester 
• 1451093-93-8 {6-chloro-4-[4-(3,5-difluoro-phenylsulfanyl)-phenyl]-3-methyl-naphthalen-2-yl}-acetic acid methyl ester 
• 1451093-92-7 {6-chloro-4-[4-(3,5-difluoro-benzenesulfonyl)-phenyl]-3-methyl-naphthalen-2-yl}-acetic acid 
• 1451093-94-9 {6-chloro-4-[4-(3,5-difluoro-benzenesulfonyl)-phenyl]-3-methyl-naphthalen-2-yl}-acetic acid methyl ester 
• 1451093-53-0 {4-[4-(3,5-difluoro-benzenesulfonyl)-phenyl]-6-fluoro-3-methyl-naphthalen-2-yl}-acetic acid 
• 1451093-55-2 {4-[4-(3,5-difluoro-benzenesulfonyl)-phenyl]-6-fluoro-3-methyl-naphthalen-2-yl}-acetic acid methyl ester 

Relevant academic research and scientific papers

AMIDO-BENZYL SULFOXIDE DERIVATIVES

The present invention relates to certain amido-benzyl sulfoxide compounds, pharmaceutical compositions comprising such compounds, and methods of treatment of an NAMPT-mediated disease or condition in a subject, selected from solid or liquid tumor, rheumat

SUBSTITUTED NAPHTHYLACETIC ACIDS

The invention is concerned with the compounds of formula (I): and pharmaceutically acceptable salts thereof, wherein R1, R2, R3 and X are defined in the detailed description and claims. In addition, the present invention r